Revolution Medicines (RVMD) Stock Insights

RVMD$199.70—
BiotechnologyLarge CapGrowth Stock
Compare
Market cap$34.87BEnterprise value—Revenue (TTM)$197.56MMarket positionTop 25%

Score

56
Neutral
Value
49
Quality
21
Growth
97

Insights

  • Revenue by product
Revenue by product
PeriodValue
FY2020Collaboration Revenue Related Party: 42983000.0
FY2021Collaboration Revenue Member: 29390000.0
FY2022Collaboration Revenue Member: 35380000.0

Revolution Medicines (RVMD) Stock Insights

RVMD price $199.70 —

Ticker
RVMD
Price
$199.70
Change
—
Market cap
$34.87B
Dividend yield
0.00%
Beta
1.43
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
56
Value
49
Quality
21
Growth
97

Stocklytics score rationale: value 49, quality 21, growth 97.

AI Score 35. Revolution Medicines, Inc. has a high price of $199.7 with a market cap of $42.8 billion, but it is in the clinical development stage with significant negative margins, including a net profit margin of -9.5%

Insights

Revenue by product
PeriodValue
FY2020Collaboration Revenue Related Party: 42983000.0
FY2021Collaboration Revenue Member: 29390000.0
FY2022Collaboration Revenue Member: 35380000.0

Insights · Forecast · Financials · Learn

Stocklytics home · Screener